Intravenous immunoglobulin (IVIg) treatment can help you fight off infections if you have a weakened immune system or other diseases. Some people may have IVIg instead of other medications (such ...

Lakmini Girihagamage appearing on behalf of the Attorney General, informed the Maligakanda Magistrate today that laboratory ...

A new trial finds that intravenous immunoglobulin stabilises kidney function and slows damage in patients with chronic antibody-mediated rejection.

Severe autoimmune-mediated neuropathies, such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and ...

Advances in our understanding of the pathogenesis of rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of immunoglobulin-based therapy as a ...

The following is a summary of “Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a ...

Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...

Court was today (19) informed that the controversial “substandard immunoglobulin vials” which caused widespread controversy in the country, contained harmful and highly dangerous types of bacteria and ...

Atrasentan reduced urine protein-to-creatinine ratio by 38% compared with 3% for placebo at week 36. The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ...

Inebilizumab significantly reduced the risk of treated and AC-determined IgG4-RD flare by 87% compared with placebo. The Food and Drug Administration (FDA) has approved Uplizna ® (inebilizumab ...

The mean immunoglobulin decline was 77% at 12 weeks. Most adults with uncontrolled Graves' disease responded favorably to once-weekly batoclimab in a phase 2a trial. Image: Adobe Stock During the ...